IPSC - Century Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IPSC is currently covered by 4 analysts with an average price target of $3.93. This is a potential upside of $2.29 (139.63%) from yesterday's end of day stock price of $1.64.

Century Therapeutics's activity chart (see below) currently has 47 price targets and 56 ratings on display. The stock rating distribution of IPSC is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12.85% with an average time for these price targets to be met of 91.77 days.

Highest price target for IPSC is $6.6, Lowest price target is $2, average price target is $3.93.

Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 21-Apr-2026. First documented stock forecast 13-Jul-2021.

Currently out of the existing stock ratings of IPSC, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 23-May-2022

$5

$3.63 (264.96%)

$2

6 months ago
(21-Apr-2026)

2/13 (15.38%)

$2.7 (117.39%)

274

Hold Since 13-Mar-2026

$2

$0.63 (45.99%)

$2

7 months 8 days ago
(13-Mar-2026)

2/5 (40%)

$-0.34 (-14.53%)

100

Buy Since 10-Oct-2022

$6.6

$5.23 (381.75%)

$6.6

8 months 9 days ago
(11-Feb-2026)

0/6 (0%)

$4.85 (277.14%)

Buy Since 13-Jul-2021

$4

$1.68 (72.41%)

$4

9 months 1 days ago
(20-Jan-2026)

0/5 (0%)

$2.08 (108.33%)

Buy Since 31-Oct-2022

$5

1 years 6 months 23 days ago
(28-Mar-2025)

0/2 (0%)

$4.44 (792.86%)

Show more analysts

Please expand the browser size to see the chart

What is IPSC (Century Therapeutics) average time for price targets to be met?

On average it took 92 days for the stock forecasts to be reached, with an average price target met ratio of 12.85%.

Which analyst most recently updated their price target on IPSC (Century Therapeutics)?

Mitchell Kapoor

Which analyst has the most public recommendations on IPSC (Century Therapeutics)?

Mitchell Kapoor has 20 price targets and 11 ratings on IPSC

Which analyst is the currently most bullish on IPSC (Century Therapeutics)?

Geoff Meacham with the highest potential upside of $17.63

Which analyst is the currently most reserved on IPSC (Century Therapeutics)?

Daina Graybosch with the lowest potential downside of -$0.32
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?